Skip to content
investormap

Heal Capital

Venture capital

RollingLast verified 6 Nov 2026

Heal Capital is a European healthtech VC fund investing €1M–€5M in pre-seed to Series A rounds, backing digital technologies in and around healthcare systems.

5 deals in the last 24 months, latest 12 May 2026. From its website and its deals in the news.

Key facts

Stages
Pre-seed, Seed, Series A
Sectors
Healthtech
Ticket
€1M–€5M
Typical round size
€7.6M (median of its recent deals, not a ticket)
Leads rounds
25% of recent deals with a known role
Eligible countries
Not stated
Provider based in
Germany
Timing
Rolling applications
Focus
digital tech in healthcare; European healthtech companies; healthcare B2B automated with AI; AI agents for consumer health
Does not invest in
classic biotech
How to apply
Apply route unknown

Recent deals

Deals in the last 24 months
CompanyRoundSectorsAmountRoleAnnounced
DittoSeedAI & machine learning, Healthtech, Consumer apps€7.6Mlead12 May 2026
ApherisSeries AB2B SaaS, Healthtech, Biotech & pharma€20.1Mparticipant14 Aug 2025
CGC Genomics · SwitzerlandPre-seedBiotech & pharma€1.7M–16 Apr 2025
ApherisSeedAI & machine learning€8.7Mparticipant24 Mar 2025
Apheris AISeries A€7.4Mparticipant28 Jan 2025

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

Status history

  • 7 Nov 2026: Uncertain → Rolling (profiles: investor activity)
  • 6 Nov 2026: Rolling → Uncertain (freshness: investor activity)
  • 6 Nov 2026: Rolling (first extraction)

Something wrong or out of date? Report an error.

Work at Heal Capital? Claim this profile to confirm what you invest in.